Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of Humana Inc (NYSE: HUM) closed at $227.14 in the last session, down -7.58% from day before closing price of $245.77. In other words, the price has decreased by -$7.58 from its previous closing price. On the day, 3.0 million shares were traded.
Ratios:
We take a closer look at HUM’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.72.
On November 06, 2024, BofA Securities Upgraded its rating to Neutral which previously was Underperform and also upped its target price recommendation from $247 to $308.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 14 ’25 when Rechtin James A. bought 6,530 shares for $229.25 per share. The transaction valued at 1,496,984 led to the insider holds 30,474 shares of the business.
Diamond Susan M bought 10,959 shares of HUM for $2,732,134 on Apr 08 ’25. On Feb 24 ’25, another insider, Huval Timothy S., who serves as the Former Chief Administrative Of of the company, bought 1,247 shares for $258.58 each.
Valuation Measures:
As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.06, and their Forward P/E ratio for the next fiscal year is 15.46. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.48. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.23 while its Price-to-Book (P/B) ratio in mrq is 1.54.
Stock Price History:
Over the past 52 weeks, HUM has reached a high of $406.46, while it has fallen to a 52-week low of $212.45. The 50-Day Moving Average of the stock is -12.98%, while the 200-Day Moving Average is calculated to be -19.27%.
Shares Statistics:
A total of 120.69M shares are outstanding, with a floating share count of 120.43M. Insiders hold about 0.22% of the company’s shares, while institutions hold 95.33% stake in the company.
Earnings Estimates
The current rating of Humana Inc (HUM) is the result of assessments by 23.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is $2.59, with high estimates of $3.9 and low estimates of $1.58.
Analysts are recommending an EPS of between $16.98 and $15.93 for the fiscal current year, implying an average EPS of $16.35. EPS for the following year is $14.5, with 24.0 analysts recommending between $18.38 and $10.55.
Revenue Estimates
According to 16 analysts, the current quarter’s revenue is expected to be $31.85B. It ranges from a high estimate of $32.35B to a low estimate of $31.41B. As of the current estimate, Humana Inc’s year-ago sales were $29.54BFor the next quarter, 16 analysts are estimating revenue of $31.48B. There is a high estimate of $32.08B for the next quarter, whereas the lowest estimate is $30.69B.
A total of 20 analysts have provided revenue estimates for HUM’s current fiscal year. The highest revenue estimate was $128.03B, while the lowest revenue estimate was $124.47B, resulting in an average revenue estimate of $126.61B. In the same quarter a year ago, actual revenue was $117.76BBased on 20 analysts’ estimates, the company’s revenue will be $130.51B in the next fiscal year. The high estimate is $139.68B and the low estimate is $121.01B.
